论文部分内容阅读
国家药品监督管理局自1998年8月19日正式挂牌运转仅4个多月,即令人感到新的药品监督执法主体所放射出的灼灼之光。正如郑筱萸局长所说,新的国家药品监督管理机构的组建,不是职能的简单迭加,而是在此基础上质的飞跃。整章建制工作紧锣密鼓,一系列跨世纪的战略性规划正在实施。日前,本刊记者就本刊读者所关心的问题采访了分管政策法规工作的国家药品监督管理局办公室主任曹文庄。 记者:《中华人民共和国药品管理法》颁布实施14年来,极大地规范了我国药品生产、流通与使用等环节
Since the State Drug Administration formally started operation on August 19, 1998, for just over 4 months, people feel the flash of light emitted by the new drug supervision and law enforcement body. As Secretary-General Zheng Xiaowu said, the formation of a new national drug regulatory agency is not a simple superposition of functions but a qualitative leap forward. The whole chapter is in full swing, with a series of cross-century strategic plans being implemented. A few days ago, our correspondents interviewed Cao Wenzhuang, director of the State Drug Administration’s office in charge of policies and regulations on issues of concern to our readers. Reporter: Since the promulgation and implementation of the “Drug Administration Law of the People’s Republic of China” 14 years ago, it has greatly regulated the links between the production, circulation and use of drugs in China